Page 203 - 110413CHI_BR_DF_JB_ID11494_FinalCut_ABC_send_15_WEBblaetter_kl

203 Jahresbericht 2008 – 2009

Implantable Access Port in oncological pati-ents (PORTAS 2 Trial: NCT 006600444): Tri-als. 9(1):60

89. Koch M, Nielsen GP, Yoon SS: Malignant tu-mors of blood vessels: Angiosarcomas, he-mangioendotheliomas, and hemangioperi-cytomas: J Surg Oncol. 97(4):321-329. 2,183 90. Kock HJ, Huber FX, Hillmeier J, Jäger R, Volk-mann R, Handschin AE, Letsch R, Meeder PJ: In Vitro Studies on Various PMMA Bone Cements: A First Comparison of NewMaterials for Arthro-plasty. Z Orthop Unfallchir. 146(1): 108-13 91. Köninger J, Seiler CM, Sauerland S, Wente MN, Reidel MA, Müller MW, Friess H, Büchler MW: Duodenum-preserving pancreatic head resection-a randomized controlled trial com-paring the original Beger Procedure with the Berne modification (ISRCTN No:50638764). Surgery. 143(4):490-8. 2,977

92. Köninger J, Wente MN, Müller-Stich BP, di Mola FF, Gutt CN, Hinz U, Müller MW, Friess H, Büchler MW: R2 resection in pancreatic cancer - does it make sense ?. Langenbeck Arch Surg. 393(6):929-34. 1,496

93. Kremer M, Hines IN: Natural killer T cells and non-alcoholic fatty liver disease: Fat chews on the immune system. World J Gastroente-rol. 14(3) : 487-8

94. Kulaksiz H, Weiss KH, Gotthardt D, Adler G, Stremmel W, Schaible A, Dogan A, Stiehl A, Sauer P: Is stenting necessary after balloon dilation of post-transplantation biliary stric-tures? Results of a prospective comparative study. Endoskopy. 40(9):746-51. 3,605 95. Langer R, Ott K, Specht K, Becker K, Lordick F, Burian M, Herrmann K, Schrattenholz A, Cahill MA, Schwaiger M, Hofler H, Wester HJ: Protein expression profiling in esophageal adenocarcinoma patients indicates associa-tion of heat-shock protein 27 expression and chemotherapy response: Clin Cancer Res. 14(24):8279-87: 6,177

96. Lichtenstern C, Nguyen TH, Schemmer P, Hoppe-Tichy T, Weigand MA: Ef f icacy of caspofungin in invasive candidiasis and can-didemia-de-escalation strategy. Mycoses. 51(1):35-46. 0,959

97. Linke GR, Borovicka J, Schneider P, Zerz A, Warschkow R, Lange J, Müller-Stich BP: Is a barium swallow complementary to endosco-py essential in the preoperative assessment of laparoscopic antireflux and hiatal hernia

surgery?. Surg Endosc. 22(1): 96-100. 1,969 98. Linke GR, Zerz A, Tutuian R, Marra F, Warsch-kow R, Müller-Stich BP, Borovicka J: Efficacy of Laparoscopic Mesh-Augmented Hiatoplasty in GERD and Symptomatic Hiatal Hernia: Stu-dy Using Combined Impedance-pH Monito-ring: J Gastrointest Surg. 12(5):816-21: 2,265 99. Loos M, Giese NA, Kleeff J, Giese T, Gaida MM, Bergmann F, Laschinger M, W Büchler M, Friess H: Clinical significance and regula-tion of the costimulatory molecule B7-H1 in pancreatic cancer. Cancer Lett. 268(1):98-109. 3,277

100. Loos M, Kleeff J, Friess H, Büchler MW: Sur-gical treatment of pancreatic cancer. Ann NY Acad Sci. 1138:169-80. 1,93

101. Loos M, Kleeff J, Friess H, Büchler MW: Ap-proaches to localized pancreatic cancer. Curr Oncol Rep. 10(3): 212-9

102. López-Benítez R, Schlieter M, Hallscheidt PJ, Radeleff BA, Kauffmann G, Richter GM, Schmidt J, Engelmann G: Successful ar te-rial thrombolysis and percutaneous trans-luminal angioplasty for early hepatic artery thrombosis after split liver transplantation in a four-month-old baby. Pediatr Transplant. 12(5):606-10: 2,004

103. Lordick F, Ott K, Weitz J, Jäger D: The evol-ving role of catumaxomab in gastric cancer. Expert Opin Biol Th. 8(9):1407-15. 2,705 104. Lordick F, Ott K, Werner J, Weitz J, Jäger D: Multimodale Therapie des Magenkarzinoms. Focus Onkologie. 1-2: 61-66

105. Lordick F, Ruers T, Aust DE, Collette L, Dow-ney RJ, Hajjam ME, Flamen P, Haustermans K, Ilson D, Julié C, Krause BJ, Newiger H, Ott K, Roth A, Cutsem EV, Weber WA, Lutz MP: European Organisation of Research and Treatment of Cancer (EORTC) Gastro-intestinal Group: Workshop on the role of metabolic imaging in the neoadjuvant treat-ment of gastrointestinal cancer. Eur J Cancer. 44(13):1807-19. 4,167

106. Lorenzen S, Brücher B, Zimmermann F, Gei-nitz H, Riera J, Schuster T, Roethling N, Höf-ler H, Ott K, Peschel C, Siewert JR, Molls M, Lordick F: Neoadjuvant continuous infusion of weekly 5-fluorouracil and escalating doses of oxaliplatin plus concurrent radiation in lo-cally advanced oesophageal squamous cell carcinoma: results of a phase I/II trial. Brit J Cancer. 99(7):1020-6. 4,459